SEI Investments’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,734
Closed -$16.6K 3140
2025
Q3
$16.6K Sell
17,734
-196
-1% -$193 ﹤0.01% 2811
2025
Q2
$22.9K Sell
17,930
-8,613
-32% -$8.65K ﹤0.01% 2779
2025
Q1
$26.6K Buy
26,543
+10,983
+71% +$11.6K ﹤0.01% 2728
2024
Q4
$14.1K Sell
15,560
-2,643
-15% -$2.59K ﹤0.01% 2719
2024
Q3
$27.3K Sell
18,203
-357
-2% -$391 ﹤0.01% 2660
2024
Q2
$12.9K Buy
18,560
+4,089
+28% +$3.55K ﹤0.01% 2644
2024
Q1
$13.8K Buy
14,471
+4,070
+39% +$3.96K ﹤0.01% 2608
2023
Q4
$11.5K Sell
10,401
-3,434
-25% -$5.1K ﹤0.01% 2601
2023
Q3
$26K Buy
13,835
+303
+2% +$870 ﹤0.01% 2588
2023
Q2
$48.5K Buy
13,532
+305
+2% +$964 ﹤0.01% 2621
2023
Q1
$44.5K Buy
13,227
+1,119
+9% +$3.36K ﹤0.01% 2634
2022
Q4
$18.8K Buy
+12,108
New +$18K ﹤0.01% 2508
2022
Q3
Sell
-11,982
Closed -$15K 2664
2022
Q2
$15K Buy
+11,982
New +$27.5K ﹤0.01% 2634

Other funds holding CTSO

SEI Investments's CTSO Position: Q4 2025 in Review

SEI Investments sold out of Cytosorbents Corp (CTSO) in Q4 2025, closing a stake of 17,734 shares — an estimated $16.6K sold.

SEI Investments first reported a position in CTSO in Q2 2022 and held it in 13 quarters. The position peaked at $48.5K in Q2 2023. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2025.

  • SEI Investments reported no remaining Cytosorbents Corp position as of Q4 2025 after selling out during the quarter.
  • SEI Investments sold 17,734 Cytosorbents Corp shares in Q4 2025, an estimated $16.6K.
  • SEI Investments first reported a position in Cytosorbents Corp in Q2 2022 and held it in 13 quarters.
  • SEI Investments's Cytosorbents Corp position peaked at $48.5K in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2025.

Based on SEI Investments's 13F filing for Q4 2025, filed 13 Feb 2026.